{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T02:07:12Z","timestamp":1771553232990,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T00:00:00Z","timestamp":1718323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T00:00:00Z","timestamp":1718323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s12013-024-01349-y","type":"journal-article","created":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T11:01:46Z","timestamp":1718362906000},"page":"2387-2399","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Inhibition of ASAP1 Modulates the Tumor Immune Microenvironment and Suppresses Lung Cancer Metastasis via the p-STAT3 Signaling Pathway"],"prefix":"10.1007","volume":"82","author":[{"given":"Hongye","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongcun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunfan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingge","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yishuai","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,14]]},"reference":[{"key":"1349_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.5114\/wo.2021.103829","volume":"25","author":"KC Thandra","year":"2021","unstructured":"Thandra, K. C., Barsouk, A., Saginala, K., Aluru, J. S., & Barsouk, A. (2021). Epidemiology of lung cancer. Contemporary Oncology\/Wsp\u00f3\u0142czesna Onkologia, 25, 45\u201352.","journal-title":"Contemporary Oncology\/Wsp\u00f3\u0142czesna Onkologia"},{"key":"1349_CR2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ccm.2019.11.001","volume":"41","author":"WD Travis","year":"2020","unstructured":"Travis, W. D. (2020). Lung cancer pathology: current concepts. Clinics in Chest Medicine, 41, 67\u201385.","journal-title":"Clinics in Chest Medicine"},{"key":"1349_CR3","doi-asserted-by":"publisher","first-page":"8661","DOI":"10.3390\/ijms22168661","volume":"22","author":"R Nooreldeen","year":"2021","unstructured":"Nooreldeen, R., & Bach, H. (2021). Current and future development in lung cancer diagnosis. International Journal of Molecular Sciences, 22, 8661","journal-title":"International Journal of Molecular Sciences"},{"key":"1349_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ccm.2019.10.001","volume":"41","author":"BC Bade","year":"2020","unstructured":"Bade, B. C., & Cruz, C. S. D. (2020). Lung cancer 2020: epidemiology, etiology, and prevention. Clinics in Chest Medicine, 41, 1\u201324","journal-title":"Clinics in Chest Medicine"},{"key":"1349_CR5","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/s41571-019-0316-z","volume":"17","author":"WT Iams","year":"2020","unstructured":"Iams, W. T., Porter, J., & Horn, L. (2020). Immunotherapeutic approaches for small-cell lung cancer. Nature Reviews Clinical Oncology, 17, 300\u2013312","journal-title":"Nature Reviews Clinical Oncology"},{"key":"1349_CR6","doi-asserted-by":"publisher","first-page":"3845","DOI":"10.7150\/ijbs.70958","volume":"18","author":"Y Zhao","year":"2022","unstructured":"Zhao, Y., Guo, S., Deng, J., Shen, J., Du, F., Wu, X., Chen, Y., Li, M., Chen, M., & Li, X. (2022). VEGF\/VEGFR-targeted therapy and immunotherapy in non-small cell lung cancer: targeting the tumor microenvironment. International Journal of Biological Sciences, 18, 3845","journal-title":"International Journal of Biological Sciences"},{"key":"1349_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22801-0","volume":"12","author":"F Wu","year":"2021","unstructured":"Wu, F., Fan, J., He, Y., Xiong, A., Yu, J., Li, Y., Zhang, Y., Zhao, W., Zhou, F., & Li, W. (2021). Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancer. Nature Communications, 12, 2540","journal-title":"Nature Communications"},{"key":"1349_CR8","doi-asserted-by":"publisher","first-page":"7072","DOI":"10.7150\/thno.57803","volume":"11","author":"C-H Hsieh","year":"2021","unstructured":"Hsieh, C.-H., Hsieh, H.-C., Shih, F.-H., Wang, P.-W., Yang, L.-X., Shieh, D.-B., & Wang, Y.-C. (2021). An innovative NRF2 nano-modulator induces lung cancer ferroptosis and elicits an immunostimulatory tumor microenvironment. Theranostics, 11, 7072.","journal-title":"Theranostics"},{"key":"1349_CR9","doi-asserted-by":"publisher","first-page":"6206","DOI":"10.3390\/cancers13246206","volume":"13","author":"R Chandra","year":"2021","unstructured":"Chandra, R., Karalis, J. D., Liu, C., Murimwa, G. Z., Voth Park, J., Heid, C. A., Reznik, S. I., Huang, E., Minna, J. D., & Brekken, R. A. (2021). The colorectal cancer tumor microenvironment and its impact on liver and lung metastasis. Cancers, 13, 6206","journal-title":"Cancers"},{"key":"1349_CR10","doi-asserted-by":"publisher","first-page":"R921","DOI":"10.1016\/j.cub.2020.06.081","volume":"30","author":"NM Anderson","year":"2020","unstructured":"Anderson, N. M., & Simon, M. C. (2020). The tumor microenvironment. Current Biology, 30, R921\u2013R925","journal-title":"Current Biology"},{"key":"1349_CR11","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.3390\/cancers13092053","volume":"13","author":"CM Neophytou","year":"2021","unstructured":"Neophytou, C. M., Panagi, M., Stylianopoulos, T., & Papageorgis, P. (2021). The role of tumor microenvironment in cancer metastasis: Molecular mechanisms and therapeutic opportunities. Cancers, 13, 2053","journal-title":"Cancers"},{"key":"1349_CR12","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1038\/onc.2010.6","volume":"29","author":"T M\u00fcller","year":"2010","unstructured":"M\u00fcller, T., Stein, U., Poletti, A., Garzia, L., Rothley, M., Plaumann, D., Thiele, W., Bauer, M., Galasso, A., & Schlag, P. (2010). ASAP1 promotes tumor cell motility and invasiveness, stimulates metastasis formation in vivo, and correlates with poor survival in colorectal cancer patients. Oncogene, 29, 2393\u20132403","journal-title":"Oncogene"},{"key":"1349_CR13","doi-asserted-by":"publisher","first-page":"4352","DOI":"10.1158\/0008-5472.CAN-07-5237","volume":"68","author":"D Lin","year":"2008","unstructured":"Lin, D., Watahiki, A., Bayani, J., Zhang, F., Liu, L., Ling, V., Sadar, M. D., English, J., Fazli, L., & So, A. (2008). ASAP1, a gene at 8q24, is associated with prostate cancer metastasis. Cancer Research, 68, 4352\u20134359","journal-title":"Cancer Research"},{"key":"1349_CR14","first-page":"280","volume":"7","author":"T Hou","year":"2014","unstructured":"Hou, T., Yang, C., Tong, C., Zhang, H., Xiao, J., & Li, J. (2014). Overexpression of ASAP1 is associated with poor prognosis in epithelial ovarian cancer. International Journal of Clinical and Experimental Pathology, 7, 280","journal-title":"International Journal of Clinical and Experimental Pathology"},{"key":"1349_CR15","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41419-023-05648-9","volume":"14","author":"W Xie","year":"2023","unstructured":"Xie, W., Han, Z., Zuo, Z., Xin, D., Chen, H., Huang, J., Zhu, S., Lou, H., Yu, Z., & Chen, C. (2023). ASAP1 activates the IQGAP1\/CDC42 pathway to promote tumor progression and chemotherapy resistance in gastric cancer. Cell Death & Disease, 14, 124","journal-title":"Cell Death & Disease"},{"key":"1349_CR16","doi-asserted-by":"publisher","first-page":"1610635","DOI":"10.3389\/pore.2022.1610635","volume":"28","author":"S Bang","year":"2022","unstructured":"Bang, S., Jee, S., Son, H., Cha, H., Sim, J., Kim, Y., Park, H., Myung, J., Kim, H., & Paik, S. (2022). Clinicopathological Implications of ASAP1 Expression in Hepatocellular Carcinoma. Pathology and Oncology Research, 28, 1610635","journal-title":"Pathology and Oncology Research"},{"key":"1349_CR17","doi-asserted-by":"publisher","first-page":"14355","DOI":"10.3390\/ijms241814355","volume":"24","author":"H Park","year":"2023","unstructured":"Park, H., Son, H., Cha, H., Song, K., Bang, S., Jee, S., Kim, H., Myung, J., Shin, S.-J., & Cha, C. (2023). ASAP1 Expression in Invasive Breast Cancer and Its Prognostic Role. International Journal of Molecular Sciences, 24, 14355","journal-title":"International Journal of Molecular Sciences"},{"key":"1349_CR18","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1166\/jbn.2024.3814","volume":"20","author":"J He","year":"2024","unstructured":"He, J., Liu, H., Cai, J., Shen, S., Wang, J., & Liu, H. (2024). ASAP1 Promotes Cholangiocarcinoma Progression via Wnt\/\u03b2-Catenin Pathway. Journal of Biomedical Nanotechnology, 20, 701\u2013711","journal-title":"Journal of Biomedical Nanotechnology"},{"key":"1349_CR19","doi-asserted-by":"publisher","first-page":"442","DOI":"10.3390\/ijms20020442","volume":"20","author":"CE Tanna","year":"2019","unstructured":"Tanna, C. E., Goss, L. B., Ludwig, C. G., & Chen, P.-W. (2019). Arf GAPs as regulators of the actin cytoskeleton\u2014an update. International Journal of Molecular Sciences, 20, 442.","journal-title":"International Journal of Molecular Sciences"},{"key":"1349_CR20","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.isci.2019.11.015","volume":"22","author":"A Gasilina","year":"2019","unstructured":"Gasilina, A., Vitali, T., Luo, R., Jian, X., & Randazzo, P. A. (2019). The ArfGAP ASAP1 controls actin stress fiber organization via its N-BAR domain. IScience, 22, 166\u2013180","journal-title":"IScience"},{"key":"1349_CR21","doi-asserted-by":"publisher","first-page":"e0182282","DOI":"10.1371\/journal.pone.0182282","volume":"12","author":"M Tong","year":"2017","unstructured":"Tong, M., Wang, J., Jiang, N., Pan, H., & Li, D. (2017). Correlation between p-STAT3 overexpression and prognosis in lung cancer: A systematic review and meta-analysis. PLoS One, 12, e0182282","journal-title":"PLoS One"},{"key":"1349_CR22","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/s41419-021-03844-z","volume":"12","author":"Z Liu","year":"2021","unstructured":"Liu, Z., Ma, L., Sun, Y., Yu, W., & Wang, X. (2021). Targeting STAT3 signaling overcomes gefitinib resistance in non-small cell lung cancer. Cell Death & Disease, 12, 561","journal-title":"Cell Death & Disease"},{"key":"1349_CR23","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ejca.2019.03.017","volume":"114","author":"Y Liu","year":"2019","unstructured":"Liu, Y., Zhang, H., Wang, Z., Wu, P., & Gong, W. (2019). 5-Hydroxytryptamine1a receptors on tumour cells induce immune evasion in lung adenocarcinoma patients with depression via autophagy\/pSTAT3. European Journal of Cancer, 114, 8\u201324","journal-title":"European Journal of Cancer"},{"key":"1349_CR24","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.humimm.2020.02.004","volume":"81","author":"L Yuan","year":"2020","unstructured":"Yuan, L., & Ye, J. (2020). Fan D: The B7-H4 gene induces immune escape partly via upregulating the PD-1\/STAT3 pathway in non-small cell lung cancer. Human Immunology, 81, 254\u2013261","journal-title":"Human Immunology"},{"key":"1349_CR25","first-page":"341","volume":"19","author":"B Groner","year":"2008","unstructured":"Groner, B., Lucks, P., & Borghouts, C. (2008). The function of Stat3 in tumor cells and their microenvironment[C]\/\/Seminars in cell & developmental biology. Academic Press, 19, 341\u2013350.","journal-title":"Academic Press"},{"key":"1349_CR26","doi-asserted-by":"publisher","first-page":"e124","DOI":"10.1002\/mco2.124","volume":"3","author":"HQ Wang","year":"2022","unstructured":"Wang, H. Q., Man, Q. W., Huo, F. Y., Gao, X., Lin, H., Li, S. R., Wang, J., Su, F. C., Cai, L., & Shi, Y. (2022). STAT3 pathway in cancers: Past, present, and future. MedComm, 3, e124.","journal-title":"MedComm"},{"key":"1349_CR27","doi-asserted-by":"publisher","first-page":"4011","DOI":"10.1073\/pnas.070552297","volume":"97","author":"PA Randazzo","year":"2000","unstructured":"Randazzo, P. A., Andrade, J., Miura, K., Brown, M. T., Long, Y.-Q., Stauffer, S., Roller, P., & Cooper, J. A. (2000). The Arf GTPase-activating protein ASAP1 regulates the actin cytoskeleton. Proceedings of the National Academy of Sciences, 97, 4011\u20134016","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"1349_CR28","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/s41591-018-0044-4","volume":"24","author":"N Priego","year":"2018","unstructured":"Priego, N., Zhu, L., Monteiro, C., Mulders, M., Wasilewski, D., Bindeman, W., Doglio, L., Mart\u00ednez, L., & Mart\u00ednez-Saez, E. (2018). Ram\u00f3n y Cajal S: STAT3 labels a subpopulation of reactive astrocytes required for brain metastasis. Nature Medicine, 24, 1024\u20131035","journal-title":"Nature Medicine"},{"key":"1349_CR29","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/s41388-020-01566-8","volume":"40","author":"W-H Lin","year":"2021","unstructured":"Lin, W.-H., Chang, Y.-W., Hong, M.-X., Hsu, T.-C., Lee, K.-C., Lin, C., & Lee, J.-L. (2021). STAT3 phosphorylation at Ser727 and Tyr705 differentially regulates the EMT\u2013MET switch and cancer metastasis. Oncogene, 40, 791\u2013805","journal-title":"Oncogene"},{"key":"1349_CR30","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/onc.2016.197","volume":"36","author":"U Saini","year":"2017","unstructured":"Saini, U., Naidu, S., ElNaggar, A. C., Bid, H. K., Wallbillich, J. J., Bixel, K., Bolyard, C., Suarez, A. A., Kaur, B., & Kuppusamy, P. (2017). Elevated STAT3 expression in ovarian cancer ascites promotes invasion and metastasis: a potential therapeutic target. Oncogene, 36, 168\u2013181","journal-title":"Oncogene"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-024-01349-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-024-01349-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-024-01349-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T14:21:50Z","timestamp":1727792510000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-024-01349-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,14]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["1349"],"URL":"https:\/\/doi.org\/10.1007\/s12013-024-01349-y","relation":{},"ISSN":["1085-9195","1559-0283"],"issn-type":[{"value":"1085-9195","type":"print"},{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,14]]},"assertion":[{"value":"4 June 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The experiment met the ethical requirements and was approved by the Ethics Committee of the Fourth Hospital of Hebei Medical University (No. 2022KY252).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}